It has also been noted that at lower, sub-toxic doses, many of these plant-derived activators of AMPK have a long history of use as traditional herbal medicine and as reference chemicals that continue to inspire the development of pharmacological activators of AMPK for the treatment of conditions such as insulin resistance, inflammation, metabolic disease and cancer [32,33]. The gene discussed is PRKAA2; the disease is Other metabolic disease.